Roberto Pili

  • 11420 Citations
  • 53 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

2015

Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models

Shen, L., Sundstedt, A., Ciesielski, M., Miles, K. M., Celander, M., Adelaiye, R., Orillion, A., Ciamporcero, E., Ramakrishnan, S., Ellis, L., Fenstermaker, R., Abrams, S. I., Eriksson, H., Leanderson, T., Olsson, A. & Pili, R., Feb 2015, In : Cancer Immunology Research. 3, 2, p. 136-148 13 p.

Research output: Contribution to journalArticle

48 Scopus citations

Testicular cancer, version 2.2015: Clinical pactice guidelines in oncology

Motzer, R. J., Jonasch, E., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., Chang, S. S., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Gupta, S., Hancock, S. L., Kim, J. J., Kuzel, T. M., Lam, E. T., Lau, C., Levine, E. G., Lin, D. W., Michaelson, M. D., Olencki, T. & 12 others, Pili, R., Plimack, E. R., Rampersaud, E. N., Redman, B. G., Ryan, C. J., Sheinfeld, J., Shuch, B., Sircar, K., Somer, B., Wilder, R. B., Dwyer, M. & Kumar, R., Jun 1 2015, In : JNCCN Journal of the National Comprehensive Cancer Network. 13, 6, p. 772-799 28 p.

Research output: Contribution to journalReview article

Open Access
69 Scopus citations

Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

Kirk, J. S., Schaarschuch, K., Dalimov, Z., Lasorsa, E., Ku, S. Y., Ramakrishnan, S., Hu, Q., Azabdaftari, G., Wang, J., Pili, R. & Ellis, L., 2015, In : Oncotarget. 6, 5, p. 3136-3146 11 p.

Research output: Contribution to journalArticle

Open Access
38 Scopus citations
2016

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): A double-blind, placebo-controlled, randomised, phase 3 trial

Haas, N. B., Manola, J., Uzzo, R. G., Flaherty, K. T., Wood, C. G., Kane, C., Jewett, M., Dutcher, J. P., Atkins, M. B., Pins, M., Wilding, G., Cella, D., Wagner, L., Matin, S., Kuzel, T. M., Sexton, W. J., Wong, Y. N., Choueiri, T. K., Pili, R., Puzanov, I. & 5 others, Kohli, M., Stadler, W., Carducci, M., Coomes, R. & Dipaola, R. S., May 14 2016, In : The Lancet. 387, 10032, p. 2008-2016 9 p.

Research output: Contribution to journalArticle

294 Scopus citations

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

Wentink, M. Q., Broxterman, H. J., Lam, S. W., Boven, E., Walraven, M., Griffioen, A. W., Pili, R., Van Der Vliet, H. J., De Gruijl, T. D. & Verheul, H. M. W., Oct 11 2016, In : British Journal of Cancer. 115, 8, p. 940-948 9 p.

Research output: Contribution to journalArticle

2 Scopus citations

Androgen Receptor Modulation Optimized for Response (ARMOR) phase i and II studies: Galeterone for the treatment of castration-resistant prostate cancer

Montgomery, B., Eisenberger, M. A., Rettig, M. B., Chu, F., Pili, R., Stephenson, J. J., Vogelzang, N. J., Koletsky, A. J., Nordquist, L. T., Edenfield, W. J., Mamlouk, K., Ferrante, K. J. & Taplin, M. E., Mar 15 2016, In : Clinical Cancer Research. 22, 6, p. 1356-1363 8 p.

Research output: Contribution to journalArticle

48 Scopus citations

Can post-transcription modifiers change the course of prostate cancer?

Qian, D. Z. & Pili, R., Apr 19 2016, Prostate Cancer: Translational and Emerging Therapies. CRC Press, p. 179-194 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Radovich, M., Kiel, P. J., Nance, S. M., Niland, E. E., Parsley, M. E., Ferguson, M. E., Jiang, G., Ammakkanavar, N. R., Einhorn, L. H., Cheng, L., Nassiri, M., Davidson, D. D., Rushing, D. A., Loehrer, P. J., Pili, R., Hanna, N., Thomas Callaghan, J., Skaar, T. C., Helft, P. R., Shahda, S. & 2 others, O'Neil, B. H. & Schneider, B. P., 2016, In : Oncotarget. 7, 35, p. 56491-56500 10 p.

Research output: Contribution to journalArticle

38 Scopus citations

Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation

Wang, J., Papanicolau-Sengos, A., Chintala, S., Wei, L., Liu, B., Hu, Q., Miles, K. M., Conroy, J. M., Glenn, S. T., Costantini, M., Magi-Galluzzi, C., Signoretti, S., Choueiri, T., Gallucci, M., Sentinelli, S., Fazio, V. M., Poeta, M. L., Liu, S., Morrison, C. & Pili, R., May 24 2016, In : Oncotarget. 7, 21, p. 29901-29915 15 p.

Research output: Contribution to journalArticle

20 Scopus citations

Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer

Ellis, L., Ku, S. Y., Li, Q., Azabdaftari, G., Seliski, J., Olson, B., Netherby, C. S., Tang, D. G., Abrams, S. I., Goodrich, D. W. & Pili, R., Sep 15 2016, In : Prostate. 76, 13, p. 1192-1202 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts

Wei, L., Chintala, S., Ciamporcero, E., Ramakrishnan, S., Elbanna, M., Wang, J., Hu, Q., Glenn, S. T., Murakami, M., Liu, L., Gomez, E. C., Sun, Y., Conroy, J., Miles, K. M., Malathi, K., Ramaiah, S., Anbarasu, A., Woloszynska-Read, A., Johnson, C. S., Conroy, J. & 3 others, Liu, S., Morrison, C. D. & Pili, R., 2016, In : Oncotarget. 7, 47, p. 76374-76389 16 p.

Research output: Contribution to journalArticle

18 Scopus citations

Genomic profiling of collecting duct renal carcinoma

Chintala, S. & Pili, R., 2016, In : Aging. 8, 10, p. 2260-2261 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma

Ramakrishnan, S., Ku, S. Y., Ciamporcero, E., Miles, K. M., Attwood, K., Chintala, S., Shen, L., Ellis, L., Sotomayor, P., Swetzig, W., Huang, R., Conroy, D., Orillion, A., Das, G. & Pili, R., Jan 1 2016, In : BMC Cancer. 16, 1, 617.

Research output: Contribution to journalArticle

11 Scopus citations

Histone deacetylase inhibitors as immunomodulators in cancer therapeutics

Shen, L., Orillion, A. & Pili, R., Mar 2016, In : Epigenomics. 8, 3, p. 415-428 14 p.

Research output: Contribution to journalReview article

37 Scopus citations

Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

Pokuri, V. K., Syed, J. R., Yang, Z., Field, E. P., Cyriac, S., Pili, R., Levine, E. G., Azabdaftari, G., Trump, D. L., Guru, K. & George, S., Feb 1 2016, In : Clinical Genitourinary Cancer. 14, 1, p. e59-e65

Research output: Contribution to journalArticle

31 Scopus citations

Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer

Sternberg, C., Armstrong, A., Pili, R., Ng, S., Huddart, R., Agarwal, N., Khvorostenko, D., Lyulko, O., Brize, A., Vogelzang, N., Delva, R., Harza, M., Thanos, A., James, N., Werbrouck, P., Bögemann, M., Hutson, T., Milecki, P., Chowdhury, S., Gallardo, E. & 6 others, Schwartsmann, G., Pouget, J. C., Baton, F., Nederman, T., Tuvesson, H. & Carducci, M., Aug 1 2016, In : Journal of Clinical Oncology. 34, 22, p. 2636-2643 8 p.

Research output: Contribution to journalArticle

44 Scopus citations

YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage

Ciamporcero, E., Shen, H., Ramakrishnan, S., Yu Ku, S., Chintala, S., Shen, L., Adelaiye, R., Miles, K. M., Ullio, C., Pizzimenti, S., Daga, M., Azabdaftari, G., Attwood, K., Johnson, C., Zhang, J., Barrera, G. & Pili, R., Mar 24 2016, In : Oncogene. 35, 12, p. 1541-1553 13 p.

Research output: Contribution to journalArticle

49 Scopus citations
2017

A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])

Pili, R., Jegede, O., Carducci, M. A., Manola, J., Groteluschen, D. L., Appleman, L. L., Liu, G., Shanks, J. C., Dakhil, S. R., Dutcher, J. & DiPaola, R. S., Dec 2017, In : Clinical Genitourinary Cancer. 15, 6, p. 642-651.e1

Research output: Contribution to journalArticle

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: A multicentre, single-arm phase I/II clinical trial

Pili, R., Liu, G., Chintala, S., Verheul, H., Rehman, S., Attwood, K., Lodge, M. A., Wahl, R., Martin, J. I., Miles, K. M., Paesante, S., Adelaiye, R., Godoy, A., King, S., Zwiebel, J. & Carducci, M. A., Mar 28 2017, In : British Journal of Cancer. 116, 7, p. 874-883 10 p.

Research output: Contribution to journalArticle

30 Scopus citations

Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer

Ramakrishnan, S., Hu, Q., Krishnan, N., Wang, D., Smit, E., Granger, V., Rak, M., Attwood, K., Johnson, C., Morrison, C., Pili, R., Chatta, G., Guru, K., Gueron, G., McNally, L., Wang, J. & Woloszynska-Read, A., Dec 1 2017, In : Cell Death and Disease. 8, 12, 3217.

Research output: Contribution to journalArticle

6 Scopus citations

Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model

Affronti, H. C., Long, M. D., Rosario, S. R., Gillard, B. M., Karasik, E., Boerlin, C. S., Pellerite, A. J., Foster, B. A., Attwood, K., Pili, R., Wilton, J. H., Campbell, M. J. & Smiraglia, D. J., Jan 1 2017, In : Oncotarget. 8, 61, p. 103758-103774 17 p.

Research output: Contribution to journalArticle

4 Scopus citations

Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma

Orillion, A., Hashimoto, A., Damayanti, N., Shen, L., Adelaiye-Ogala, R., Arisa, S., Chintala, S., Ordentlich, P., Kao, C., Elzey, B., Gabrilovich, D. & Pili, R., Sep 1 2017, In : Clinical Cancer Research. 23, 17, p. 5187-5201 15 p.

Research output: Contribution to journalArticle

95 Scopus citations

EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming

Adelaiye-Ogala, R., Budka, J., Damayanti, N. P., Arrington, J., Ferris, M., Hsu, C. C., Chintala, S., Orillion, A., Miles, K. M., Shen, L., Elbanna, M., Ciamporcero, E., Arisa, S., Pettazzoni, P., Draetta, G. F., Seshadri, M., Hancock, B., Radovich, M., Kota, J., Buck, M. & 9 others, Keilhack, H., McCarthy, B. P., Persohn, S. A., Territo, P. R., Zang, Y., Irudayaraj, J., Tao, W. A., Hollenhorst, P. & Pili, R., Dec 1 2017, In : Cancer Research. 77, 23, p. 6651-6666 16 p.

Research output: Contribution to journalArticle

19 Scopus citations

Immunomodulation by entinostat in renal cell carcinoma patients receiving high-dose interleukin 2: A multicenter, single-arm, phase I/II trial (NCI-CTEP#7870)

Pili, R., Quinn, D. I., Hammers, H. J., Monk, P., George, S., Dorff, T. B., Olencki, T., Shen, L., Orillion, A., Lamonica, D., Fragomeni, R. S., Szabo, Z., Hutson, A., Groman, A., Perkins, S. M., Piekarz, R. & Carducci, M. A., Dec 1 2017, In : Clinical Cancer Research. 23, 23, p. 7199-7208 10 p.

Research output: Contribution to journalArticle

26 Scopus citations
3 Scopus citations

Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth

Deng, X., Shao, G., Zhang, H. T., Li, C., Zhang, D., Cheng, L., Elzey, B. D., Pili, R., Ratliff, T. L., Huang, J. & Hu, C. D., Mar 2 2017, In : Oncogene. 36, 9, p. 1223-1231 9 p.

Research output: Contribution to journalArticle

36 Scopus citations

Real-Time Multiplex Kinase Phosphorylation Sensors in Living Cells

Damayanti, N. P., Buno, K., Cui, Y., Voytik-Harbin, S. L., Pili, R., Freeman, J. & Irudayaraj, J. M. K., Aug 25 2017, In : ACS Sensors. 2, 8, p. 1225-1230 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Selenomethionine and methyl selenocysteine: Multiple-dose pharmacokinetics in selenium-replete men

Marshall, J. R., Burk, R. F., Ondracek, R. P., Hill, K. E., Perloff, M., Davis, W., Pili, R., George, S. & Bergan, R., Jan 1 2017, In : Oncotarget. 8, 16, p. 26312-26322 11 p.

Research output: Contribution to journalArticle

10 Scopus citations

Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device

Huang, W., Chang, C. L., Brault, N. D., Gur, O., Wang, Z., Jalal, S. I., Low, P. S., Ratliff, T. L., Pili, R. & Savran, C. A., Feb 7 2017, In : Lab on a Chip. 17, 3, p. 415-428 14 p.

Research output: Contribution to journalArticle

12 Scopus citations

Targeting the programmed cell death-1 pathway in genitourinary tumors: Current progress and future perspectives

Mann, S. A., Lopez-Beltran, A., Massari, F., Pili, R., Fiorentino, M., Koch, M. O., Kaimakliotis, H. Z., Wang, L., Scarpelli, M., Ciccarese, C., Moch, H., Montironi, R. & Cheng, L., Jan 1 2017, In : Current drug metabolism. 18, 8, p. 700-711 12 p.

Research output: Contribution to journalReview article

17 Scopus citations

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Adra, N., Cheng, L. & Pili, R., Jun 2017, In : Clinical Genitourinary Cancer. 15, 3, p. e517-e519

Research output: Contribution to journalArticle

4 Scopus citations
2018

Ageing, Disability, and Spinal Cord Injury: Some Issues of Analysis

Pili, R., Gaviano, L., Pili, L. & Petretto, D. R., Jan 1 2018, In : Current Gerontology and Geriatrics Research. 2018, 4017858.

Research output: Contribution to journalReview article

2 Scopus citations

Consensus guidelines for the use and interpretation of angiogenesis assays

Nowak-Sliwinska, P., Alitalo, K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., van Beijnum, J. R., Bender, R. H. F., Bergers, G., Bikfalvi, A., Bischoff, J., Böck, B. C., Brooks, P. C., Bussolino, F., Cakir, B., Carmeliet, P., Castranova, D., Cimpean, A. M. & 66 others, Cleaver, O., Coukos, G., Davis, G. E., De Palma, M., Dimberg, A., Dings, R. P. M., Djonov, V., Dudley, A. C., Dufton, N. P., Fendt, S. M., Ferrara, N., Fruttiger, M., Fukumura, D., Ghesquière, B., Gong, Y., Griffin, R. J., Harris, A. L., Hughes, C. C. W., Hultgren, N. W., Iruela-Arispe, M. L., Irving, M., Jain, R. K., Kalluri, R., Kalucka, J., Kerbel, R. S., Kitajewski, J., Klaassen, I., Kleinmann, H. K., Koolwijk, P., Kuczynski, E., Kwak, B. R., Marien, K., Melero-Martin, J. M., Munn, L. L., Nicosia, R. F., Noel, A., Nurro, J., Olsson, A. K., Petrova, T. V., Pietras, K., Pili, R., Pollard, J. W., Post, M. J., Quax, P. H. A., Rabinovich, G. A., Raica, M., Randi, A. M., Ribatti, D., Ruegg, C., Schlingemann, R. O., Schulte-Merker, S., Smith, L. E. H., Song, J. W., Stacker, S. A., Stalin, J., Stratman, A. N., Van de Velde, M., van Hinsbergh, V. W. M., Vermeulen, P. B., Waltenberger, J., Weinstein, B. M., Xin, H., Yetkin-Arik, B., Yla-Herttuala, S., Yoder, M. C. & Griffioen, A. W., Aug 1 2018, In : Angiogenesis. 21, 3, p. 425-532 108 p.

Research output: Contribution to journalReview article

118 Scopus citations

Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer

Ciamporcero, E., Daga, M., Pizzimenti, S., Roetto, A., Dianzani, C., Compagnone, A., Palmieri, A., Ullio, C., Cangemi, L., Pili, R. & Barrera, G., Feb 1 2018, In : Free Radical Biology and Medicine. 115, p. 447-457 11 p.

Research output: Contribution to journalArticle

26 Scopus citations

Dietary protein restriction reprograms tumor-associated macrophages and enhances immunotherapy

Orillion, A., Damayanti, N. P., Shen, L., Adelaiye-Ogala, R., Affronti, H., Elbanna, M., Chintala, S., Ciesielski, M., Fontana, L., Kao, C., Elzey, B. D., Ratliff, T. L., Nelson, D. E., Smiraglia, D., Abrams, S. I. & Pili, R., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6383-6395 13 p.

Research output: Contribution to journalArticle

10 Scopus citations

Low-protein diet in cancer: Ready for prime time?

Pili, R. & Fontana, L., Jul 1 2018, In : Nature Reviews Endocrinology. 14, 7, p. 384-386 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C. J., Zhou, X. C., Heath, E. I., Taplin, M. E., Mayer, T., Stein, M. N., Bubley, G. J., Pili, R., Hudson, T., Kakarla, R., Abbas, M. M., Anders, N. M., Dowling, D., King, S., Bruns, A. B., Wagner, W. D., Drake, C. G., Antonarakis, E. S., Eisenberger, M. A., Denmeade, S. R. & 3 others, Rudek, M. A., Rosner, G. L. & Carducci, M. A., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

10 Scopus citations

Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer a secondary analysis of a randomized clinical trial

Armstrong, A. J., Anand, A., Edenbrandt, L., Bondesson, E., Bjartell, A., Widmark, A., Sternberg, C. N., Pili, R., Tuvesson, H., Nordle, Ö., Carducci, M. A. & Morris, M. J., Jul 2018, In : JAMA Oncology. 4, 7, p. 944-951 8 p.

Research output: Contribution to journalArticle

19 Scopus citations

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)

Monk, P., Liu, G., Stadler, W. M., Geyer, S., Huang, Y., Wright, J., Villalona-Calero, M., Wade, J., Szmulewitz, R., Gupta, S., Mortazavi, A., Dreicer, R., Pili, R., Dawson, N., George, S. & Garcia, J. A., Oct 1 2018, In : Investigational New Drugs. 36, 5, p. 919-926 8 p.

Research output: Contribution to journalArticle

4 Scopus citations

Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma

Wentink, M. Q., Verheul, H. M. W., Pal, S. K., George, S., Voortman, J., Danchaivijitr, P., Adelaiye, R., Poslinski, D., Groman, A., Hutson, A. & Pili, R., Feb 2018, In : Clinical Genitourinary Cancer. 16, 1, p. e1-e9

Research output: Contribution to journalArticle

3 Scopus citations

Phase I trials of anti-ENPP3 antibody–drug conjugates in advanced refractory renal cell carcinomas

Thompson, J. A., Motzer, R. J., Molina, A. M., Choueiri, T. K., Heath, E. I., Redman, B. G., Sangha, R. S., Ernst, D. S., Pili, R., Kim, S. K., Reyno, L., Wiseman, A., Trave, F., Anand, B., Morrison, K., Doñate, F. & Kollmannsberger, C. K., Sep 15 2018, In : Clinical Cancer Research. 24, 18, p. 4399-4406 8 p.

Research output: Contribution to journalArticle

9 Scopus citations

Therapeutic targeting of sunitinib-induced AR phosphorylation in renal cell carcinoma

Adelaiye-Ogala, R., Damayanti, N. P., Orillion, A. R., Arisa, S., Chintala, S., Titus, M. A., Kao, C. & Pili, R., Jun 1 2018, In : Cancer Research. 78, 11, p. 2886-2896 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

Therapeutic targeting of TFE3/IRS-1/PI3K/mTOR axis in translocation renal cell carcinoma

Damayanti, N. P., Budka, J. A., Khella, H. W. Z., Ferris, M. W., Ku, S. Y., Kauffman, E., Wood, A. C., Ahmed, K., Chintala, V. N., Adelaiye-Ogala, R., Elbanna, M., Orillion, A., Chintala, S., Kao, C., Marston Linehan, W., Yousef, G. M., Hollenhorst, P. C. & Pili, R., Dec 1 2018, In : Clinical Cancer Research. 24, 23, p. 5977-5989 13 p.

Research output: Contribution to journalArticle

17 Scopus citations
2019

Antitumor activity and mechanistic characterization of APE1/ReF-1 inhibitors in bladder cancer

Fishel, M. L., Xia, H., McGeown, J., McIlwain, D. W., Elbanna, M., Craft, A. A., Kaimakliotis, H. Z., Sandusky, G. E., Zhang, C., Pili, R., Kelley, M. R. & Jerde, T. J., 2019, In : Molecular cancer therapeutics. 18, 11, p. 1947-1960 14 p.

Research output: Contribution to journalArticle

2 Scopus citations

A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors

Michaelson, M. D., Gupta, S., Agarwal, N., Szmulewitz, R., Powles, T., Pili, R., Bruce, J. Y., Vaishampayan, U., Larkin, J., Rosbrook, B., Wang, E., Murphy, D., Wang, P., Lechuga, M. J., Valota, O. & Shepard, D. R., Sep 1 2019, In : Oncologist. 24, 9, p. 1151-e817

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

CDK12-altered prostate cancer: Clinical features and therapeutic outcomes to standard systemic therapies, poly (ADP-ribose) polymerase inhibitors, and PD-1 inhibitors

Antonarakis, E. S., Velho, P. I., Fu, W., Wang, H., Agarwal, N., Santos, V. S., Maughan, B. L., Pili, R., Adra, N., Sternberg, C. N., Vlachostergios, P. J., Tagawa, S. T., Bryce, A. H., McNatty, A. L., Reichert, Z. R., Dreicer, R., Sartor, O., Lotan, T. L. & Hussain, M., 2019, In : JCO Precision Oncology. 3, p. 370-381 12 p.

Research output: Contribution to journalArticle

Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors

Scognamiglio, G., De Chiara, A., Parafioriti, A., Armiraglio, E., Fazioli, F., Gallo, M., Aversa, L., Camerlingo, R., Cacciatore, F., Colella, G., Pili, R. & de Nigris, F., Nov 26 2019, In : British Journal of Cancer. 121, 11, p. 979-982 4 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA

Gawroński, A. R., Lin, Y. Y., McConeghy, B., Lebihan, S., Asghari, H., Koçkan, C., Orabi, B., Adra, N., Pili, R., Collins, C. C., Sahinalp, S. C. & Hach, F., Apr 23 2019, In : Nucleic acids research. 47, 7, e38.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)

Bunch, B., Krishnan, N., Greenspan, R. D., Ramakrishnan, S., Attwood, K., Yan, L., Qi, Q., Wang, D., Morrison, C., Omilian, A., Bshara, W., Pili, R., Trump, D. L., Johnson, C. & Woloszynska, A., Sep 2 2019, In : Cell Cycle. 18, 17, p. 2055-2066 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Tasquinimod targets suppressive myeloid cells in the tumor microenvironment

Shen, L. & Pili, R., Jan 1 2019, In : OncoImmunology. 8, 10, e1072672.

Research output: Contribution to journalArticle

1 Scopus citations